AG00DA5R

55134-13-9 | Narasin

Chemical structure of Narasin, CAS 55134-13-9
AG00DA5R
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 55134-13-9
Catalog Number AG00DA5R(AGN-PC-0SIPX9)
Chemical Name Narasin
EC Number 611-230-1
IUPAC Name (2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid
InChI InChI=1S/C43H72O11/c1-12-30(35(46)27(8)34(45)28(9)36-23(4)21-24(5)37(51-36)31(13-2)39(47)48)38-25(6)22-26(7)42(52-38)18-15-32(44)43(54-42)20-19-40(11,53-43)33-16-17-41(49,14-3)29(10)50-33/h15,18,23-34,36-38,44-45,49H,12-14,16-17,19-22H2,1-11H3,(H,47,48)/t23-,24-,25-,26+,27-,28-,29-,30-,31+,32+,33+,34+,36+,37+,38-,40-,41+,42-,43-/m0/s1
InChI Key VHKXXVVRRDYCIK-CWCPJSEDSA-N
MDL Number MFCD00133653
Molecular Formula C43H72O11
Molecular Weight 765.0252
SMILES C[C@@H]1[C@@](O[C@]([C@@H](C)C1)([C@@H](CC)C(O)=O)[H])([C@@H](C)[C@H](O)[C@H](C)C([C@@H]([C@]2([H])[C@@H](C)C[C@@H](C)[C@]3(O[C@@]4(CC[C@](O4)([C@@]5([H])CC[C@@]([C@H](C)O5)(CC)O)C)[C@H](O)C=C3)O2)CC)=O)[H]
UNII DZY9VU539P
Synonyms
4-methylsalinomycin, narasin, narasin A, narasin monosodium salt, narasin, Narasin A, Monteban, Compound 79891, Antibiotic C 7819B, Antibiotic A 28086A, Narasine [INN-French], Narasinum [INN-Latin], Narasino [INN-Spanish], UNII-DZY9VU539P, C 7819B, A 28086A, Antibiotic A-28086 factor A, 4-Methylsalinomycin, BRN 1678311, DZY9VU539P, Narasine, Narasino, Narasinum, AI3-29798, Lilly 79891, Salinomycin, 4-methyl-, (4S), 55134-13-9, Narasin [USAN:BAN:INN], Narasul, alpha-Ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-2H-pyran-2-acetic acid, Monteban (TN), Narasin (USP/INN), 2H-Pyran-2-acetic acid, alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-, (4S)-4-Methylsalinomycin, Narasin [USAN:USP:INN:BAN], NCGC00167550-01, C43H72O11, DSSTox_CID_26707, DSSTox_RID_81840, DSSTox_GSID_46707, SCHEMBL123401, AC1L23A4, CHEMBL2104423, DTXSID2046707, (4''S'')-4-methyl-salinomycin, Tox21_112545, ZINC85540282, CAS-55134-13-9, LS-144430, D05122, (2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid, Maxiban 72, Narasin [USAN:INN:BAN], Salinomycin, 4-methyl-, (4S)-, CID65452, Narasin from Streptomyces auriofaciens, C43-H72-O11,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited